Discussions around the manufacture of vaccines has never been more important. COVID-19 has brought to light how important having an efficient manufacturing process for vaccines is, as well as placing high demand on those providing capacity to the industry. In this webinar, BioPharma-Reporter brings together leading experts across the industry to share what has been learnt from the pandemic and how the future of vaccine production will look.
Director of Biologics
Centre for Process Innovation Limited
Associate Director, Intellectual Property and Trade Policy